DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
SEARCH
Current Location:
>
> This Story


Log in or Register to rate this News Story
Forward Printable StoryPrint Comment

 

 

Molecular Imaging Homepage

ITM enters North American partnerships to establish stable n.c.a.-Lutetium-177 supply Enhance use and supply for targeted radionuclide therapy

Generator production for Tc-99m in Australia suspended following mechanical fault Expected to take weeks to repair

James Allison, Padmanee Sharma and Ramy Ibrahim ImaginAb appoints new members to scientific advisory board

Alliance completes deal for Piramal Imaging Expanding market presence in molecular imaging

Siemens announces first global installation of Biograph Vision PET/CT System yields better temporal resolution and sensitivity than previously reported

Spectrum Dynamics launches 12 detector SPECT system The VERITON SPECT system debuted at SNMMI

Cardinal Health showcases first integrated cloud solution for nuclear medicine at SNMMI Nuctrac replaces phone and fax orders

New PET tracer could help find cure for Alzheimer's Researchers from Yale show they can measure synaptic density: SNMMI

GE launched Syntermed's Emory Cardiac Toolbox at SNMMI Affordable option for users with older SPECT systems

Combined radionuclide therapy and immunotherapy shows promise New research unveiled at SNMMI meeting

A brain showing decreases of
serotonin transporters (blue)
in the MCI group compared
to the healthy control group

Courtesy of Gwenn Smith lab

Researchers leverage PET and MR to uncover serotonin's role in Alzheimer's

by Lauren Dubinsky , Senior Reporter
Serotonin may have more to do with Alzheimer’s disease than previously thought.

A team at Johns Hopkins Medicine used PET and MR imaging to measure patients’ brain structures and levels of serotonin and found that lower levels may contribute to the onset of the disease. A report on this research was published in the September issue of Neurobiology of Disease.

Story Continues Below Advertisement

THE (LEADER) IN MEDICAL IMAGING TECHNOLOGY SINCE 1982. SALES-SERVICE-REPAIR

Special-Pricing Available on Medical Displays, Patient Monitors, Recorders, Printers, Media, Ultrasound Machines, and Cameras.This includes Top Brands such as SONY, BARCO, NDS, NEC, LG, EDAN, EIZO, ELO, FSN, PANASONIC, MITSUBISHI, OLYMPUS, & WIDE.



“The study shows that the serotonin system is affected in the early stages before memory problems are severe enough to meet criteria for dementia,” Dr. Gwenn Smith, professor and director of geriatric psychiatry and neuropsychiatry at the university, told HCB News. “We hope the study will stimulate development of medications targeting the serotonin system for use in individuals at risk for dementia.”

Previous studies have shown that Alzheimer’s and severe cognitive decline are associated with a significant loss of serotonin neurons, but it was unclear whether it was a cause or consequence of the disease.

Smith and her colleagues had 28 participants with mild cognitive impairment (MCI) and 28 healthy, matched controls undergo MR and PET exams. During the PET exams, a chemical labeled with a radioactive carbon was administered that’s similar in structure to an antidepressant, but not at a dose that would produce a pharmacological effect.

“Brain regions such as the hippocampus that are affected early in AD can be imaged in more detail with MR compared to CAT scans,” said Smith “Neurotransmitters in the brain such as serotonin and dopamine can only be imaged with selective radiotracers that are available for PET and SPECT imaging.”

They found that those with MCI had up to 38 percent less of the serotonin transporter SERT in their brains, compared to the health control group. None of the participants with MCI had higher levels of SERT than their healthy counterparts.

The participants also underwent learning and memory tests including the California Verbal Learning Test, which is scored on a scale of 0 to 80 with a higher number reflecting better memory. The healthy participants scored an average of 55.8 and those with MCI scored an average of 40.5.

For the Brief Visuospatial Memory Test, the participants were shown a series of shapes to remember and draw later. On a scale of 0 to 36, with 36 being the top score, the healthy group scored an average of 20 and those with MCI scored an average of 12.6.

The research team compared the results of the brain imaging tests with the two memory tests and found that lower serotonin transporters correlated with lower scores. For instance, those with MCI had 37 percent lower verbal memory scores and 18 percent lower levels of SERT in the hippocampus than healthy controls.

The team is currently investigating whether PET imaging of serotonin could be a marker to detect the progression of the disease, either alone or in conjunction with scans that detect amyloid.

Molecular Imaging Homepage


You Must Be Logged In To Post A Comment

Advertise
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Directory
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Requests
Gold Service Dealer Program
Receive RFP/PS
Requests
Healthcare Providers
See all
HCP Tools
Jobs/Training
Find/Fill
A Job
Parts Hunter +EasyPay
Get Parts
Quotes
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Quotes
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2018 DOTmed.com, Inc.
ALL RIGHTS RESERVED